Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine

USask VIDO-InterVac research team. (Photo: University of Saskatchewan)

Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards human clinical trials: the novel vaccine has proven highly effective in ferrets, one of the commonly used animal models for COVID-19.....

https://news.usask.ca/articles/research/2020/promising-pre-clinical-results-for-usask-vido-intervac-covid-19-vaccine.php